The pharmaceutical sector increasingly relies on both massive supply and custom production of key intermediates. Bulk supply caters to standard chemical needs with consistent quality and favorable pricing, suitable for established manufacturing methods. However, the drive for innovative drug molecules often necessitates tailored synthesis, where sp